Lexaria Bioscience LEXX
NASDAQ LEXX
$3.17 +0.08 (+2.48%)
As of: Oct 1, 2026 · 2:08 PM EDT

Lexaria Bioscience (LEXX) Other Non-Current Liabilities (2012 - 2021)

Updated

Lexaria Bioscience's Other Non-Current Liabilities was $49,989 in fiscal Q4 2021 (quarter ended Aug 31, 2021), down 44.1% from $89,393 a year earlier.

Analysis

Lexaria Bioscience (LEXX) Other Non-Current Liabilities (2012 - 2021) Analysis & Trends

From fiscal Q4 2012 onward, Lexaria Bioscience has reported Other Non-Current Liabilities for 10 quarters.

  • In earlier fiscal years, Other Non-Current Liabilities was $89,393 in FY2020.
  • The fiscal Q4 2021 figure marks the lowest quarterly Other Non-Current Liabilities in data going back to fiscal Q4 2012.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn
10 Lexaria Bioscience 3.26 Mn -12.39 Mn -
Historic Data

Historic Data

Download Data
DateValue
Aug 31, 2021 49,989.00
Aug 31, 2020 89,393.00
Jul 31, 2014 59,245.00
Apr 30, 2014 59,245.00
Jan 31, 2014 59,245.00
Oct 31, 2013 59,245.00
Jul 31, 2013 59,245.00
Apr 30, 2013 59,245.00
Jan 31, 2013 59,245.00
Oct 31, 2012 59,245.00
API Access

Lexaria Bioscience Other Non-Current Liabilities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-non-current-liabilities&ticker=LEXX&period=max&api_key=YOUR_API_KEY